Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 63 Neoplasms 40 Colorectal Neoplasms 30 Uterine Cervical Neoplasms 29 Carcinoma, Hepatocellular 23 Stomach Neoplasms 19 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Ovarian Neoplasms 16 Lung Neoplasms 15 Esophageal Neoplasms 13 Multiple Myeloma 12 Pancreatic Neoplasms 11 Endometrial Neoplasms 10 Urinary Bladder Neoplasms 9 Rectal Neoplasms 9 Motor Activity 9 Colonic Neoplasms 9 Recurrence 8 Lymphoma, Follicular 8 Melanoma 7 Lymphoma 7 Liver Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Triple Negative Breast Neoplasms 6 Sleep Initiation and Maintenance Disorders 6 Sarcopenia 6 Neuroendocrine Tumors 6 Leukemia 6 Hematologic Neoplasms 6

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Hormone Receptor Positive Breast Cancer × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡